Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide for Cryptosporidiosis in AIDS
NCT00001081Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in cryptosporidiosis, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
nitazoxanide
03
Conditions
cryptosporidiosis
Beyond the preview
Go deeper on NCT00001081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001081.